Home › Articles › Volume 6, Issue 3 › To Investigate the Prevalence of Thyroid Function te...
Moradabad, India
Original Article

To Investigate the Prevalence of Thyroid Function test Anomalies and Serum Thyroid Autoantibodies in Individuals with Vitiligo and Alopecia Areata


Volume 6, Issue 3, Pages 25-28

Author

Mamta Rani1
Affiliation:
1Department of Dermatology, Rama Medical College, Hapur, UP, India.

Corresponding Author

Mamta Rani

Abstract

Background: Alopecia areata (AA) and vitiligo are autoimmune disorders defined by the loss of hair and the presence of depigmented patches on the skin, respectively. It is often linked to other autoimmune illnesses, particularly autoimmune thyroid disorders, suggesting that autoimmunity may play a role in its development. Aim: To investigate the prevalence of thyroid function test anomalies and serum thyroid autoantibodies in individuals with vitiligo and alopecia areata. Methodology: A total of 160 patients were allocated into two groups, with 80 patients assigned to the AA group and 80 patients assigned to the vitiligo group. We retrieved demographic information, clinical features, and test findings of the patients from our system. All patients underwent analysis of thyroid function tests, including free T3, free T4, and TSH, as well as blood levels of thyroid autoantibodies (Anti-TG and anti-TPO). This research was done in compliance with the ethical criteria and received approval from the ethics committee. Results: The mean levels of free T3, free T4, and TSH were not significantly different between the AA and vitiligo groups. The mean free T3 levels were 4.23 ± 0.88 pmol/L in the AA group and 4.43 ± 0.93 pmol/L in the vitiligo group (p=0.15). Similarly, the mean free T4 levels were 16.58 ± 1.46 pmol/L in the AA group and 16.98 ± 1.45 pmol/L in the vitiligo group (p=0.21). The mean TSH levels were 2.07 ± 0.77 mIU/L in the AA group and 2.21 ± 0.75 mIU/L in the vitiligo group (p=0.11). Elevated TSH was observed in 7.5% of AA patients and 10% of vitiligo patients (p=0.14), while suppressed TSH was observed in 8.75% of AA patients and 6.25% of vitiligo patients (p=0.22). Elevated free T3 was found in 5% of AA patients and 3.75% of vitiligo patients (p=0.15), and suppressed free T3 in 1.25% of AA patients and 2.5% of vitiligo patients (p=0.21). Elevated free T4 was observed in 6.25% of AA patients and 5% of vitiligo patients (p=0.16), while suppressed free T4 was found in 2.5% of AA patients and 3.75% of vitiligo patients (p=0.11). Positive Anti-TG antibodies were found in 25% of AA patients and 22.5% of vitiligo patients (p=0.31), while positive Anti-TPO antibodies were found in 22.5% of AA patients and 20% of vitiligo patients (p=0.70). Conclusion: The study's findings on decreased thyroid functioning and thyroid autoantibodies in individuals with vitiligo and AA were in line with prior data collected from other ethnic communities.

Keywords

Vitiligo, AA, Thyroid disease, Thyroid autoantibody, TSH, T3, T4.

History

Received 03 March 2017

Accepted 07 March 2017

Author Notes

Address for correspondence* Dr Mamta Rani, Department of Dermatology, Rama Medical College, Hapur, UP, India.

Open Access

This work is licensed under the Creative Commons Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright (c) 2017 Asian Journal of Medical Research

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
6
Downloads
6
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 6
Issue Issue 3
Year 2017

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni